Sun Pharma Reports Rs 425 Crore Loss In Q1 As Generics Business Suffers
Business
Mumbai-based Sun Pharma posted a net loss of Rs 425 crore for the April-June quarter compared with a profit of Rs 2,034 crore a year earlier.
Comments